Ole DammannChief Executive Officer at kfgn|Site Operations & Services GmbH, Germany
Ole is the CEO at kfgn and member of the Pratia board. He acts as an Advisory Board Member for Clinscience.
kfgn is a group of six sites across Germany conducting clinical trials for the pharmaceutical industry. Together with Pratia the network covers 7 countries with more than 60 sites. At Pratia they are developing a virtual clinical trial platform for the conduction of clinical trials. In cooperation with their partners kfgn and Pratia are driving the digitalization of clinical research.
Ole is currently working on the digitization of clinical research and the development of new business models. He is also engaged in several projects in digital health care.